Leo O'Connor

Policy and Regulation
President Biden launches $50M initiative to improve cancer outcomes in low-income areas
The award creates five Centers for Cancer Control Research in Persistent Poverty Areas to advance key priorities of the Administration’s Cancer Moonshot.
June 26, 2023
Business Hands Cooperation Social
Payor Coverage
Report shows Medicare risked up to $888M in improper payments for molecular pathology test
The HHS Office of Inspector General analyzed Medicare Part B claims associated with payments for more than 450,000 genetic tests billed under Current Procedural Terminology (CPT) code 81408.
June 23, 2023
Money Bag Grant Award Social
Business Insights
Week in Review: Quest to offer ctDNA MRD testing | Exact Sciences develops next-gen Cologuard | Detecting Candida auris
Quest Diagnostics completed its previously announced acquisition of Haystack Oncology, a developer of minimal-residual disease (MRD) testing technology.
June 22, 2023
Leo Photo June 8
Colorectal Cancer
Next-gen Cologuard demonstrates 94% sensitivity, 91% specificity for colorectal cancer detection
The firm also entered collaborations related to next-generation technology for ultra-sensitive detection of molecular residual disease (MRD) and ongoing research, as well as for the development of its multicancer early detection (MCED) approach.
June 21, 2023
Exact Sciences Corporation Social
Tuberculosis
Qiagen describes systematic review for IGRA TB test, blood collection tubes
The study including 4,050 subjects highlights the value of the TB2 tube and the detection of CD8 T-cell responses for immunocompromised patients, a key risk group for tuberculosis disease, the firm said.
June 15, 2023
Bacteria Mycobacterium Tuberculosis Social
Business Insights
Week in Review: Biocartis layoffs | Predicting preeclampsia outcomes | Cystic fibrosis screening
Roche announced that its Cobas HPV test has been awarded WHO prequalification, expanding the cervical cancer screening tool's availability in countries that rely on the global organization’s list of prequalified suppliers to purchase tests.
June 15, 2023
Leo Photo June 8
Financial Results
Biocartis to lay off 140 people in company reorganization
The Mechelen, Belgium-based supplier of instruments and tests said the plan would reduce operating expenses by about 18 million euros annually.
June 15, 2023
Genetics Dna Money Social
Business Insights
Week in Review: Molecular testing at home | C. auris detection from blood | ASCO presentations
At-home testing got a boost this week when the FDA granted marketing authorization for the Cue Health COVID-19 Molecular Test.
June 8, 2023
Leo Photo June 8
Sepsis
Prenosis nabs $749K federal contract to study clinical utility of AI-based diagnostic tool for sepsis
The firm’s Sepsis ImmunoScore is a pathogen-agnostic, host-based digital diagnostic tool that uses artificial intelligence/machine learning to predict sepsis using clinical parameters and protein biomarkers.
June 7, 2023
Artificial Intelligence Ai Social
Regulatory Approval
Cue Health granted first traditional FDA authorization for at-home test to detect respiratory illness
The Cue COVID-19 Molecular Test detects genetic material from SARS-CoV-2 virus in nasal swabs from adults with signs and symptoms of upper respiratory infection.
June 6, 2023
Fda Button Social
Page 1 of 17
Next Page
Top Stories
Proscia Embeddings
Artificial Intelligence
Proscia launches pathology AI model toolkit
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
Crispr Cas9 Gene Editing
Emerging Technology
CRISPR patent decisions could trigger waves globally
Doctor Patient Consult
Pathology and AI
Ibex survey indicates some comfort with AI in cancer diagnostics
Olfactory Bulb Brain Cr Social
Pathology and AI
Pathologists detect microplastics in human brain tissue
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Home
Proscia launches pathology AI model toolkit
By Liz Carey
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
October 2, 2024
Proscia Embeddings
CRISPR patent decisions could trigger waves globally
By LabPulse.com staff writers
Canceling a pair of patents in Europe will affect a broad network of biotech companies that have bought and sold the rights to pursue gene-slicing research, according to a September 25 report published in MIT Technology Review.
September 30, 2024
Crispr Cas9 Gene Editing
Ibex survey indicates some comfort with AI in cancer diagnostics
By LabPulse.com staff writers
A recent survey reports that more than 50% of U.S. adults have received an incorrect medical test result for themselves or a loved one. Additionally, 60% would trust artificial intelligence (AI) supporting medical diagnoses.
September 25, 2024
Doctor Patient Consult
Pathologists detect microplastics in human brain tissue
By Will Morton
Pathologists have detected microplastics in the olfactory bulb brain tissues of eight deceased individuals in Sao Paulo, highlighting the need for further research about their effects on human health, reports a study published in JAMA Network Open.
September 25, 2024
Olfactory Bulb Brain Cr Social
NIH establishes pandemic preparedness research network
By LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.
September 19, 2024
Infectious Diseases Research Social
CDC adds commercial lab contracts for infectious disease, bird flu testing
By Liz Carey
Clinical laboratories incentivized to develop diagnostic tests earlier.
September 17, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
Multiregional clinical trial data on FDA watch for U.S. applicability
By LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Fda Sign Dc Social
Seegene launches 3rd RUO mpox assay
By LabPulse.com staff writers
After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.
September 10, 2024
3 D Monkeypox Infecting Cell Social
Hospital labs targeted in proposed Calif. hospital licensing regulations
By Liz Carey
Proposed changes could require some hospitals to materially alter their current operations, according to advisers.
September 11, 2024
Regulation Wheel Social
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Dna Sequencing Data Analysis Social
ADLM releases guidance for blood lipid assessment, lipoprotein testing
By LabPulse.com staff writers
Document outlines recommendations for standardizing clinical lipid testing workflows.
September 4, 2024
Blood Test Samples Lab Social
Seegene, Springer Nature launch PCR innovation program
By LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Research Money Social
Page 1 of 125
Next Page